These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1284 related articles for article (PubMed ID: 17402563)

  • 1. [Aging and retinal vascular diseases].
    Takagi H
    Nippon Ganka Gakkai Zasshi; 2007 Mar; 111(3):207-30; discussion 231. PubMed ID: 17402563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy.
    Watanabe D; Suzuma K; Matsui S; Kurimoto M; Kiryu J; Kita M; Suzuma I; Ohashi H; Ojima T; Murakami T; Kobayashi T; Masuda S; Nagao M; Yoshimura N; Takagi H
    N Engl J Med; 2005 Aug; 353(8):782-92. PubMed ID: 16120858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lifestyle-related diseases and anti-aging ophthalmology: suppression of retinal and choroidal pathologies by inhibiting renin-angiotensin system and inflammation].
    Ishida S
    Nippon Ganka Gakkai Zasshi; 2009 Mar; 113(3):403-22; discussion 423. PubMed ID: 19348185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Connection of pericyte-angiopoietin-Tie-2 system in diabetic retinopathy: friend or foe?
    Cai J; Ruan Q; Chen ZJ; Han S
    Future Med Chem; 2012 Nov; 4(17):2163-76. PubMed ID: 23190105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel role of erythropoietin in proliferative diabetic retinopathy.
    Takagi H; Watanabe D; Suzuma K; Kurimoto M; Suzuma I; Ohashi H; Ojima T; Murakami T
    Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S62-4. PubMed ID: 17481772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.
    Aiello LP; Avery RL; Arrigg PG; Keyt BA; Jampel HD; Shah ST; Pasquale LR; Thieme H; Iwamoto MA; Park JE
    N Engl J Med; 1994 Dec; 331(22):1480-7. PubMed ID: 7526212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cell biology of intraocular vascular diseases].
    Ishibashi T
    Nippon Ganka Gakkai Zasshi; 1999 Dec; 103(12):923-47. PubMed ID: 10643294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockade.
    Lip PL; Chatterjee S; Caine GJ; Hope-Ross M; Gibson J; Blann AD; Lip GY
    Br J Ophthalmol; 2004 Dec; 88(12):1543-6. PubMed ID: 15548809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases.
    Pe'er J; Shweiki D; Itin A; Hemo I; Gnessin H; Keshet E
    Lab Invest; 1995 Jun; 72(6):638-45. PubMed ID: 7540233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prospects and Challenges of Anti-VEGF Drug Treatment for Pathological Angiogenesis of the Retina].
    Nakamura S; Hara H
    Yakugaku Zasshi; 2021; 141(12):1307-1317. PubMed ID: 34853203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of neovascular glaucoma. Etiopathogenesis and treatment.
    Dumbrăveanu L; Cușnir V; Bobescu D
    Rom J Ophthalmol; 2021; 65(4):315-329. PubMed ID: 35087972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.
    Stalmans I
    Verh K Acad Geneeskd Belg; 2005; 67(4):229-76. PubMed ID: 16334858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of VEGF in diseases of the retina].
    Barquet LA
    Arch Soc Esp Oftalmol; 2015 Mar; 90 Suppl 1():3-5. PubMed ID: 25925044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor a in intraocular vascular disease.
    Miller JW; Le Couter J; Strauss EC; Ferrara N
    Ophthalmology; 2013 Jan; 120(1):106-14. PubMed ID: 23031671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy].
    Watanabe D
    Nippon Ganka Gakkai Zasshi; 2007 Nov; 111(11):892-8. PubMed ID: 18051819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy.
    Babapoor-Farrokhran S; Jee K; Puchner B; Hassan SJ; Xin X; Rodrigues M; Kashiwabuchi F; Ma T; Hu K; Deshpande M; Daoud Y; Solomon S; Wenick A; Lutty GA; Semenza GL; Montaner S; Sodhi A
    Proc Natl Acad Sci U S A; 2015 Jun; 112(23):E3030-9. PubMed ID: 26039997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the angiotensin II type 1 receptor in the pathogenesis of diabetic retinopathy: effects of blood pressure control and beyond.
    Clermont A; Bursell SE; Feener EP
    J Hypertens Suppl; 2006 Mar; 24(1):S73-80. PubMed ID: 16601577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The angiopoietin/Tie-2 system regulates pericyte survival and recruitment in diabetic retinopathy.
    Cai J; Kehoe O; Smith GM; Hykin P; Boulton ME
    Invest Ophthalmol Vis Sci; 2008 May; 49(5):2163-71. PubMed ID: 18436850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Müller cell-derived VEGF is a significant contributor to retinal neovascularization.
    Bai Y; Ma JX; Guo J; Wang J; Zhu M; Chen Y; Le YZ
    J Pathol; 2009 Dec; 219(4):446-54. PubMed ID: 19768732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropilin-1 modulates vascular endothelial growth factor-induced poly(ADP-ribose)-polymerase leading to reduced cerebrovascular apoptosis.
    Mey L; Hörmann M; Schleicher N; Reuter P; Dönges S; Kinscherf R; Gassmann M; Gerriets T; Al-Fakhri N
    Neurobiol Dis; 2013 Nov; 59():111-25. PubMed ID: 23816753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 65.